First Nebraska Trust Co Buys Shares of 74,054 Danaher Corporation $DHR

First Nebraska Trust Co purchased a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 74,054 shares of the conglomerate’s stock, valued at approximately $14,106,000. Danaher comprises approximately 1.1% of First Nebraska Trust Co’s investment portfolio, making the stock its 20th largest holding.

A number of other hedge funds and other institutional investors have also modified their holdings of DHR. Bank of Nova Scotia acquired a new position in shares of Danaher in the second quarter valued at approximately $24,178,000. Kirtland Hills Capital Management LLC acquired a new stake in Danaher during the second quarter worth approximately $1,466,000. Compass Financial Management LLC acquired a new stake in Danaher during the second quarter worth approximately $145,000. Elevation Point Wealth Partners LLC purchased a new stake in Danaher in the 2nd quarter worth approximately $2,127,000. Finally, Alta Advisers Ltd acquired a new position in Danaher in the 2nd quarter valued at $414,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Evercore restated an “outperform” rating and set a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Wells Fargo & Company decreased their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Finally, Stifel Nicolaus lowered their price target on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Stock Up 1.6%

Shares of DHR opened at $219.42 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company’s fifty day moving average is $195.80 and its two-hundred day moving average is $192.61. The firm has a market cap of $154.25 billion, a PE ratio of 38.97, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 EPS. Analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.